A new artificial intelligence system called DeepRare has beaten experienced rare-disease physicians at their own specialty, ...

Preparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however. At the University of Pennsylvania Health System, doctors are nudged to talk ...

Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...

The AI in precision medicine market shows strong growth prospects driven by the need for personalized therapies amid rising chronic diseases. Key opportunities include advancements in AI for ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Rare diseases can often be difficult to diagnose because their symptoms can overlap with a variety of conditions. One such disease is acute hepatic porphyria (AHP), a rare genetic disease with ...

In the rapidly evolving realm of genetics, the integration of artificial intelligence (AI) has ushered in new perspectives on therapeutic approaches and evolutionary processes. Traditional genetic ...

A Stanford-led study published in Nature on Feb. 26 found that age-related changes witnessed in diseases like Alzheimer’s may be related to a relatively untapped area of research in the brain. The ...

The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night after years of financial struggles. This means that all of the extremely ...